These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4081060)

  • 1. Pharmacological investigation of the mechanisms of platelet-activating factor induced mortality in the mouse.
    Young JM; Maloney PJ; Jubb SN; Clark JS
    Prostaglandins; 1985 Oct; 30(4):545-51. PubMed ID: 4081060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAF-acether-induced mortality in mice: protection by benzodiazepines.
    Tannière-Zeller M; Rochette L; Bralet J
    Drugs Exp Clin Res; 1989; 15(11-12):553-8. PubMed ID: 2576913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pharmacologic analysis of the action of platelet-activating factor in the induction of hindpaw edema in the rat.
    Goldenberg MM; Meurer RD
    Prostaglandins; 1984 Aug; 28(2):271-8. PubMed ID: 6505225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paf-acether-induced death in mice: involvement of arachidonate metabolites and beta-adrenoceptors.
    Criscuoli M; Subissi A
    Br J Pharmacol; 1987 Jan; 90(1):203-9. PubMed ID: 2880624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic modulation of PAF-induced mortality in mice.
    Carlson RP; O'Neill-Davis L; Chang J
    Agents Actions; 1987 Aug; 21(3-4):379-81. PubMed ID: 3120513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A lethal role of platelet activating factor in anaphylactic shock in mice.
    Terashita Z; Imura Y; Shino A; Nishikawa K
    J Pharmacol Exp Ther; 1987 Oct; 243(1):378-83. PubMed ID: 3118009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharide Cross-Tolerance Delays Platelet-Activating Factor-Induced Sudden Death in Swiss Albino Mice: Involvement of Cyclooxygenase in Cross-Tolerance.
    Jacob SP; Lakshmikanth CL; Chaithra VH; Kumari TR; Chen CH; McIntyre TM; Marathe GK
    PLoS One; 2016; 11(4):e0153282. PubMed ID: 27064683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of inhibitors of arachidonic acid metabolism on Paf-induced gastric mucosal necrosis and haemoconcentration.
    Wallace JL; Whittle BJ
    Br J Pharmacol; 1986 Oct; 89(2):415-22. PubMed ID: 3096408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoid protection against PAF-acether toxicity in mice.
    Myers A; Ramey E; Ramwell P
    Br J Pharmacol; 1983 Jun; 79(2):595-8. PubMed ID: 6652344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic inhibition of complement induced granulocyte margination by BW755C and calcium channel blockers.
    Issekutz AC; Rochon Y; Ripley M
    Int J Immunopharmacol; 1985; 7(6):791-800. PubMed ID: 3000960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition by leukotriene inhibitors, and calcium and platelet-activating factor antagonists, of acute gastric and intestinal damage in arthritic rats and in cholinomimetic-treated mice.
    Rainsford KD
    J Pharm Pharmacol; 1999 Mar; 51(3):331-9. PubMed ID: 10344635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist.
    Hwang SB; Li CL; Lam MH; Shen TY
    Lab Invest; 1985 Jun; 52(6):617-30. PubMed ID: 3925239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
    Terashita Z; Kawamura M; Takatani M; Tsushima S; Imura Y; Nishikawa K
    J Pharmacol Exp Ther; 1992 Feb; 260(2):748-55. PubMed ID: 1738121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene.
    Lefort J; Rotilio D; Vargaftig BB
    Br J Pharmacol; 1984 Jul; 82(3):565-75. PubMed ID: 6430375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid mediators of tumor necrosis factor-alpha-induced uveitis.
    Fleisher LN; Ferrell JB; Smith MG; McGahan MC
    Invest Ophthalmol Vis Sci; 1991 Jul; 32(8):2393-9. PubMed ID: 1649146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological properties of YM461, a new orally active platelet-activating factor antagonist.
    Yamada T; Saito M; Mase T; Hara H; Nagaoka H; Murase K; Tomioka K
    Lipids; 1991 Dec; 26(12):1179-83. PubMed ID: 1668114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
    Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
    J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and pharmacological modulation of antigen-induced peritonitis in actively sensitized mice.
    Zuany-Amorim C; Leduc D; Vargaftig BB; Pretolani M
    Br J Pharmacol; 1993 Oct; 110(2):917-24. PubMed ID: 7694762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-activating factor-induced ischemic bowel necrosis. An investigation of secondary mediators in its pathogenesis.
    Hsueh W; Gonzalez-Crussi F; Arroyave JL
    Am J Pathol; 1986 Feb; 122(2):231-9. PubMed ID: 3080895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist.
    Tsunoda H; Sakuma Y; Harada K; Muramoto K; Katayama S; Horie T; Shimomura N; Clark R; Miyazawa S; Okano K
    Arzneimittelforschung; 1990 Nov; 40(11):1201-5. PubMed ID: 2085331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.